U.S.-based Yarrow Bioscience is branching out, picking an autoimmune thyroid disease drug from China as its lead candidate. Through a potential $1.37 billion deal, New York-headquartered Yarrow gains ...
NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE”) and Yarrow Bioscience, Inc. (“Yarrow”) today announced that they have entered into a definitive merger ...
NEW YORK - VYNE Therapeutics Inc. (NASDAQ:VYNE) and Yarrow Bioscience Inc. announced Wednesday they have entered into a definitive merger agreement for an all-stock transaction, with the combined ...
Following closing, combined company plans to progress Yarrow’s lead program, YB-101, a potentially first-in-class anti-thyroid-stimulating hormone receptor (“TSHR”) antibody for Graves’ disease (“GD”) ...
Collaboration to focus on building a leading, US-based biotech dedicated to addressing underserved patients impacted by autoimmune and endocrinology disorders GenSci to receive $70 million ...
An Oxford botanist reflects on one of the city's most cherished specimens. The plant has been in severe decline, having previously been widespread across the UK and Ireland. Researcher Septian Andriki ...
We reveal the structural basis of transport activity and substrate selectivity of LciA, a key bicarbonate channel that is part of the CO 2-concentrating mechanism in the green alga Chlamydomonas ...
This research integrates leaf physiology, anatomy, and cell wall composition to understand species habitat specialization. The findings suggest that wet forest species vary in hydraulic function via ...
(Yicai) Dec. 16 -- Shares of Changchun High-Tech Industry Group advanced after a subsidiary of the Chinese biopharmaceutical company granted the global rights to an innovative hyperthyroidism ...
Can you chip in? As an independent nonprofit, the Internet Archive is fighting for universal access to quality information. We build and maintain all our own systems, but we don’t charge for access, ...
Can you chip in? As an independent nonprofit, the Internet Archive is fighting for universal access to quality information. We build and maintain all our own systems, but we don’t charge for access, ...